home / stock / ancn / ancn short
Short Information | Chemomab Therapeutics (NYSE:ANCN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 72,298 |
Total Actual Volume | 568,294 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 3,615 |
Average Short Percentage | 9.75% |
Is there a ANCN Short Squeeze or Breakout about to happen?
See the ANCN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $1.35 | $1.295 | $1.35 | $1.29 | 9,823 | 31 | 0.32% |
02-11-2020 | $1.34 | $1.28 | $1.34 | $1.2608 | 24,313 | 2,320 | 9.54% |
02-10-2020 | $1.32 | $1.33 | $1.36 | $1.3001 | 11,753 | 847 | 7.21% |
02-06-2020 | $1.26 | $1.29 | $1.35 | $1.26 | 33,402 | 5,870 | 17.57% |
02-05-2020 | $1.3335 | $1.30 | $1.4196 | $1.30 | 22,506 | 4,356 | 19.35% |
02-04-2020 | $1.26 | $1.27 | $1.3427 | $1.26 | 21,992 | 18 | 0.08% |
02-03-2020 | $1.345 | $1.295 | $1.345 | $1.2669 | 14,727 | 414 | 2.81% |
01-31-2020 | $1.2899 | $1.28 | $1.3475 | $1.275 | 14,952 | 1,781 | 11.91% |
01-30-2020 | $1.30 | $1.2872 | $1.30 | $1.25 | 18,676 | 3,925 | 21.02% |
01-29-2020 | $1.32 | $1.345 | $1.3607 | $1.31 | 7,282 | 1,041 | 14.3% |
01-28-2020 | $1.31 | $1.35 | $1.39 | $1.31 | 6,382 | 153 | 2.4% |
01-27-2020 | $1.39 | $1.322 | $1.45 | $1.31 | 61,717 | 11,983 | 19.42% |
01-24-2020 | $1.52 | $1.43 | $1.55 | $1.40 | 23,236 | 857 | 3.69% |
01-23-2020 | $1.46 | $1.48 | $1.4899 | $1.452 | 19,013 | 1,601 | 8.42% |
01-22-2020 | $1.47 | $1.47 | $1.5764 | $1.4603 | 18,949 | 1,682 | 8.88% |
01-21-2020 | $1.62 | $1.50 | $1.6423 | $1.50 | 30,289 | 421 | 1.39% |
01-17-2020 | $1.47 | $1.58 | $1.6421 | $1.47 | 36,039 | 4,010 | 11.13% |
01-16-2020 | $1.43 | $1.51 | $1.69 | $1.43 | 161,168 | 28,381 | 17.61% |
01-15-2020 | $1.44 | $1.435 | $1.50 | $1.43 | 13,084 | 1,747 | 13.35% |
01-14-2020 | $1.40 | $1.4526 | $1.476 | $1.39 | 18,991 | 860 | 4.53% |
News, Short Squeeze, Breakout and More Instantly...
Chemomab Therapeutics Company Name:
ANCN Stock Symbol:
NYSE Market:
Anchiano s hareholders approve all resolutions at shareholder meeting The merged company is expected to receive approximate gross proceeds from the private financing of $ 45 .5 million, which will be used to a dvance the Chemomab...
Are These 5 Biotech Penny Stocks Worth Watching? With the extraordinary times we live in, Covid has resulted in a large investor focus on biotech penny stocks. Within the stock market, there’s no shortage of interesting biotech companies to choose from. In 2021, it’s best ...
NEW YORK, NY / ACCESSWIRE / February 3, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in N...